Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14886909 | 0.88 | EPHX1 (0.47) | CNR1ALDH1A1KDM4E | |
| SCHEMBL24279226 | 0.87 | CNR1 (0.51) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL18221716 | 0.86 | CNR1 (0.47) | CNR1TRPV1 | |
| SCHEMBL2999471 | 0.86 | ALDH1A1 (0.53) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL7623261 | 0.86 | ALDH1A1 (0.53) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| Hydrochloric Acid SCHEMBL10591072 | 0.86 | KDM4E (0.47) | ALDH1A1TRPV1KDM4E | |
| SCHEMBL31284016 | 0.85 | KDM4E (0.43) | KDM4E | |
| SCHEMBL18361392 | 0.85 | CNR1 (0.43) | CNR1TRPV1 | |
| Hydrochloric Acid SCHEMBL869521 | 0.84 | ALDH1A1 (0.51) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| Hydrochloric Acid SCHEMBL1988837 | 0.84 | ALDH1A1 (0.51) | CNR1ALDH1A1HPGDTRPV1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287015-A1 | Method for Producing an Ionizable Lipid | NANOVATION THERAPEUTICS INC. (CA) | 2024-08-29 | — | — | US | disclosed |
| WO-2022246555-A1 | METHOD FOR PRODUCING AN IONIZABLE LIPID | NANOVATION THERAPEUTICS INC. (CA) | 2022-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287015-A1 | Method for Producing an Ionizable Lipid | CEL, FASN, COASY | CNR1 628/4885ALDH1A1 371/4885HPGD 2000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.